Pennant GroupPNTG +3.10%89 9-Day RSI is 82.44 as of Jul. 05, 2026. GuruFocus rates PNTG with a GF Score™ of 89/100 and a GF Value™ of $34.60 (Modestly Overvalued). The stock has 8 warning signs investors should review. Among 697 Healthcare Providers & Services companies, Pennant Group ranks worse than 94.84% on this metric.
The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.
As of today (2026-07-05), Pennant Group's 9-Day RSI is 82.44.
The industry rank for Pennant Group's 9-Day RSI or its related term are showing as below:
PNTG's 9-Day RSI is ranked worse than 94.84% of 697
companies
in the Healthcare Providers & Services industry
Industry Median: 52.67
vs PNTG: 82.44
Pennant Group (NAS:PNTG) 9-Day RSI Explanation
The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.
Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.
RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.
Pennant Group 9-Day RSI Related Terms
PNTG vs AMN, NUTX, ARDT: 9-Day RSI Comparison
For the Medical Care Facilities subindustry, Pennant Group's 9-Day RSI, along with its competitors' market caps and 9-Day RSI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Pennant Group 9-Day RSI vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Pennant Group's 9-Day RSI distribution charts can be found below:
* The bar in red indicates where Pennant Group's 9-Day RSI falls into.
* Note that the formula uses a positive value for the average loss.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Pennant Group (PNTG) has a 9-Day RSI of 82.44 as of Jul. 05, 2026. According to the industry distribution chart, Pennant Group ranks #661 out of 697 companies in the Healthcare Providers & Services industry, placing it in the top 94.8%.
Is Pennant Group's 9-Day RSI too high?
Pennant Group's current 9-Day RSI is 82.44. The Healthcare Providers & Services industry median 9-Day RSI is 52.67. Pennant Group's value of 82.44 is 56.5% above this industry median. Based on the distribution chart, Pennant Group ranks #661 out of 697 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Pennant Group has a GF Score™ of 89/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Pennant Group's 9-Day RSI compare to AMN and NUTX?
According to the Healthcare Providers & Services industry distribution chart, Pennant Group ranks #661 out of 697 companies for 9-Day RSI. This places Pennant Group in the lower half of its industry. The industry median 9-Day RSI is 52.67. Pennant Group's value of 82.44 is 56.5% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 9-Day RSI for a Healthcare Providers & Services company?
The median 9-Day RSI among Healthcare Providers & Services companies is 52.67, based on 697 companies in the industry. Companies in the top quartile (top 25%) have a 9-Day RSI significantly above this median, while those in the bottom quartile fall well below. However, 9-Day RSI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Pennant Group's current 9-Day RSI of 82.44 is 56.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 9-Day RSI mean?
A high 9-Day RSI can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median 9-Day RSI is 52.67 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Pennant Group's current 9-Day RSI is 82.44. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pennant Group stock overvalued right now?
Based on GuruFocus' analysis, Pennant Group (PNTG) is currently considered Modestly Overvalued. The stock's GF Value™ is $34.60, compared to a current price of $38.52 — trading 11.3% above its estimated fair value. The current 9-Day RSI is 82.44 and 56.5% above the Healthcare Providers & Services industry median of 52.67. Pennant Group's overall GF Score™ is 89/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 9-Day RSI calculated?
9-Day RSI is calculated from a company's financial statements. For Pennant Group (PNTG), the current 9-Day RSI is 82.44 as of Jul. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Pennant Group (PNTG) Overvalued in 2026?
Based on GuruFocus' analysis, Pennant Group stock appears to be overvalued.
The current stock price of $38.52 is trading 11.3% above its estimated GF Value™ of $34.60.
GuruFocus considers Pennant Group to be Modestly Overvalued.
Key valuation signals for PNTG:
9-Day RSI: 82.44
GF Value™: $34.60 vs. price of $38.52 (11.3% above fair value)
Industry Position: 56.5% above the Healthcare Providers & Services median (#661 of 697)
No single metric tells the full story. See the PNTG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Pennant Group Inc is engaged in providing healthcare services to patients of all ages, including the growing senior population, in the United States. It operates in multiple lines of business including home health, hospice, and senior living which includes the company's assisted living, independent living, and memory care communities across Arizona, California, Colorado, Idaho, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin, and Wyoming. It operates in two segments; home health and hospice services and senior living services. The company generates majority of its revenue from home health and hospice services segment, which includes its home health, hospice and home care businesses.
89GF Score
Get the complete analysis for PNTG
9-Day RSI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PNTG has been successfully added to your 